JPMorgan analyst James Gordon raised the firm’s price target on Genmab to DKK 3,450 from DKK 2,900 and keeps an Overweight rating on the shares.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GMAB:
JPMorgan analyst James Gordon raised the firm’s price target on Genmab to DKK 3,450 from DKK 2,900 and keeps an Overweight rating on the shares.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GMAB: